Last reviewed · How we verify

NCT04178876: CLESS

Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)

Status unknown NA Last updated 4 December 2019
What this trial tests

NA trial testing ethanol sclerotherapy in Endometrioma in 64 participants. Status unknown.

Timeline
13 September 2019
Primary endpoint
1 November 2022
1 June 2023

Quick facts

Lead sponsorCatholic University of the Sacred Heart
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment64
Start date13 September 2019
Primary completion1 November 2022
Estimated completion1 June 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Catholic University of the Sacred Heart

Who can join

Adults 18 to 35, female only, with Endometrioma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare two different laparoscopic surgical techniques (endometrioma stripping vs ethanol sclerotherapy) in terms of ovarian reserve (AMH levels), recurrence rate and pain relief.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ethanol sclerotherapy

Trials testing the same drug.

Other recruiting trials for Endometrioma

Currently open trials in the same condition.

Other Catholic University of the Sacred Heart trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04178876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing